Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.56 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MGAM | O43451 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.50 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL112927 | 0.97 | TSHR (0.53) | TSHRTET2HSD17B10GAAMGAM | |
| SCHEMBL1396293 | 0.94 | — | — | |
| SCHEMBL12329903 | 0.89 | GAA (0.55) | TSHRTET2HSD17B10GAAMGAM | |
| SCHEMBL2303378 | 0.89 | TSHR (0.52) | TSHRTET2HSD17B10GAAMGAM | |
| SCHEMBL2361759 | 0.88 | TSHR (0.50) | TSHRTET2HSD17B10GAAMGAM | |
| SCHEMBL5199404 | 0.87 | TSHR (0.43) | TSHRTET2HSD17B10GAAMGAM | |
| SCHEMBL800951 | 0.85 | — | — | |
| SCHEMBL18307349 | 0.83 | — | — | |
| SCHEMBL19174579 | 0.83 | — | — | |
| SCHEMBL5665197 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 356 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119069791-A | Organic electrolyte, sodium ion secondary battery and electric equipment | 珠海鹏辉能源有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-117866443-A | Flame-retardant silicone rubber material and preparation method and application thereof | 池州聚石化学有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-113444115-A | Synthesis method of methyl iminodiacetate of methyl borate | 石家庄圣泰化工有限公司 | 2021-09-28 | — | — | CN | claimed |
| EP-0790241-A1 | COMPLEXONES WITH THE STRUCTURE OF N-2-(AZOL-1(2)-YL)ETHYLIMINODIACETIC ACIDS, SYNTHESIS, ANALYTICAL STUDY AND BIOLOGICAL APPLICATIONS | UNIVERSIDAD NACIONAL DE EDUCACION A DISTANCIA (ES) | 1997-08-20 | — | — | EP | claimed |
| US-12637422-B2 | Ionizable cationic lipid for RNA delivery | ARCTURUS THERAPEUTICS, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| EP-4127025-B1 | COMPOSITION FOR COPPER BUMP ELECTRODEPOSITION COMPRISING A POLYAMINOAMIDE TYPE LEVELING AGENT | BASF SE (DE) | 2025-10-01 | — | — | EP | disclosed |
| CN-120058757-A | Synthesis method of methyl iminodiacetic acid borate compound | 上海泰坦科技股份有限公司 | 2025-05-30 | — | — | CN | disclosed |
| EP-4527831-A2 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | Arcturus Therapeutics, Inc. (US) | 2025-03-26 | — | — | EP | disclosed |
| US-20250090540-A1 | PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF | RELAY THERAPEUTICS, INC. | 2025-03-20 | — | — | US | disclosed |
| EP-3848417-B1 | COMPOSITION FOR COPPER ELECTROPLATING COMPRISING LEVELING AGENT | BASF SE (DE) | 2025-01-08 | — | — | EP | disclosed |
| CN-119069791-A | Organic electrolyte, sodium ion secondary battery and electric equipment | 珠海鹏辉能源有限公司 | 2024-12-03 | — | — | CN | disclosed |
| US-12134834-B2 | Composition for copper bump electrodeposition comprising a polyaminoamide type leveling agent | BASF SE (DE) | 2024-11-05 | — | — | US | disclosed |
| US-4637988-A | BINDING, ADSORPTION LANTHANIDE CHELATE COMPOUNDS | EASTMAN KODAK COMPANY (US) | 1987-01-20 | — | — | US | disclosed |
| US-4587353-A | Process for producing N-chlorosulfenyl compounds | CIBA-GEIGY CORPORATION (US) | 1986-05-06 | — | — | US | disclosed |
| US-4506001-A | Photographic recording material containing novel coordination polymer | FUJI PHOTO FILM CO., LTD. (JP) | 1985-03-19 | — | — | US | disclosed |
| US-4421693-A | INSECTICIDES, MITICIDES OR NEMATOCIDES | OTSUKA CHEMICAL CO., LTD. (JP) | 1983-12-20 | — | — | US | disclosed |
| US-4413005-A | 2,3-DIHYDRO-2,2-DIMETHYLBENZOFURAN-7-YL DERIVATIVES | OTSUKA KAGAKU YAKUHIN KABUSHIKI KAISHA (JP) | 1983-11-01 | — | — | US | disclosed |
| EP-0068875-A2 | Fluorescent chelates and labeled specific binding reagents prepared therefrom | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1983-01-05 | — | — | EP | disclosed |
| US-4358546-A | Spherical porous cross-linked copolymers of chloromethylstyrene and divinylbenzene and the derivative thereof | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1982-11-09 | — | — | US | disclosed |
| US-4277566-A | REMOVING HEAVY METALS FROM WASTE WATERS OR RECOVERING THEM FROM SEA WATER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250090540-A1 | PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF | PIK3CA, PIK3CB, PIK3CD | TSHR 4407/4885TET2 3123/4885HSD17B10 1330/4885 |
| US-12637422-B2 | Ionizable cationic lipid for RNA delivery | POLRMT, SLC27A1, SLC43A1 | TSHR 1630/4885TET2 3353/4885HSD17B10 999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.